FOLLOWUS
Contemporary treatment of Western and Chinese medicine for cardiac syndrome X
- Chinese Journal of Integrative Medicine Vol. 17, Issue 4, Pages: 314-320(2011)
- Affiliations：
1. Tianjin University of Traditional Chinese Medicine,Tianjin,China
2. Cardiovascular Department of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin,China
3. Cardiovascular Department of Guang’anmen Hospital of China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
DOI：10.1007/s11655-011-0714-2
CLC：Published：2011，
Published Online：21 April 2011，
Scan for full text
Bi, Yf., Mao, Jy., Wang, Xl. et al. Contemporary treatment of Western and Chinese medicine for cardiac syndrome X., Chin. J. Integr. Med. 17, 314–320 (2011). https://doi.org/10.1007/s11655-011-0714-2
Ying-fei Bi, Jing-yuan Mao, Xian-liang Wang, et al. Contemporary treatment of Western and Chinese medicine for cardiac syndrome X. [J]. Chinese Journal of Integrative Medicine 17(4):314-320(2011)
Bi, Yf., Mao, Jy., Wang, Xl. et al. Contemporary treatment of Western and Chinese medicine for cardiac syndrome X., Chin. J. Integr. Med. 17, 314–320 (2011). https://doi.org/10.1007/s11655-011-0714-2 DOI：
Ying-fei Bi, Jing-yuan Mao, Xian-liang Wang, et al. Contemporary treatment of Western and Chinese medicine for cardiac syndrome X. [J]. Chinese Journal of Integrative Medicine 17(4):314-320(2011) DOI： 10.1007/s11655-011-0714-2.
摘要
Clinical reports on cardiac syndrome X (CSX) have been increasing in recent years. In general
CSX does not increase the cardiovascular mortality
but it can affect the patient’s quality of life (QOL) and increase the incidence rates of cardiovascular and cerebrovascular events. Although a variety of drugs and therapies have been utilized in the clinical treatment
the management of CSX still represents a major challenge due to its unclear pathogenesis. It is necessary to explore more effective treatment programs. Many attempts have been made on trials of the Chinese medicine (CM) treatment for CSX and proved that CM has a certain advantage in efficacy to improve clinical symptoms and QOL. CM may provide a new approach for the effective treatment of CSX.
Abstract
Clinical reports on cardiac syndrome X (CSX) have been increasing in recent years. In general
CSX does not increase the cardiovascular mortality
but it can affect the patient’s quality of life (QOL) and increase the incidence rates of cardiovascular and cerebrovascular events. Although a variety of drugs and therapies have been utilized in the clinical treatment
the management of CSX still represents a major challenge due to its unclear pathogenesis. It is necessary to explore more effective treatment programs. Many attempts have been made on trials of the Chinese medicine (CM) treatment for CSX and proved that CM has a certain advantage in efficacy to improve clinical symptoms and QOL. CM may provide a new approach for the effective treatment of CSX.
关键词
cardiac syndrome Xangina pectorisWestern MedicineChinese Medicine
Keywords
cardiac syndrome Xangina pectorisWestern MedicineChinese Medicine
references
Likoff W, Seagal BL, Kasparin H. Paradox of normal elective coronary arteriogram in patients considered to have unmistakable coronary hert disease. N Eng J Med 1967;276:1063–1066.
Kemp HG. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1976;32:375–376.
Cannon RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988;61:1338–1343.
Kaski JC, ed. Chest pain with normal coronary angiograms: pathogenesis, diagnosis and management. London, UK: Kluwer Academic Publishers; 1999:1–12.
Shmilovich H, Deutsch V, Roth A, Miller H, Keren G, George J. Circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 2007;93:1071–1076.
Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, Lin SJ. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 2007;93:1064–1070.
Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: Results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006;27:1408–1415.
Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Clinical and pathophysiological implications. Circulation 1994;90:2695–2700.
Radice M, Giudici V, Pusineri E, Breghi L, Nicoli T, Peci P, et al. Different effects of acute administration of aminophylline and nitroglycerin on exercise capacity in patients with syndrome X. Am J Cardiol 1996;78:88–92.
Kaski JC, Aldama G, Cosín-Sales J. Cardiac syndrome X: diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 2004;4:179–194.
Bao ZY, Mao JL. Diagnosis and therapy of cardiac syndrome X. Adv Cardiovasc Dis (Chin) 2006;27:296–298.
Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 1999;84:854–856.
Sen N, Tavil Y, Erdamar H, Yazici HU, Cakir E, Akgül EO, et al. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. Anadolu Kardiyol Derg 2009;9:371–379.
Erdamar H, Sen N, Tavil Y, Yazici HU, Turfan M, Poyraz F, et al. The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X. Coron Artery Dis 2009;20:238–244.
Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X. Eur Heart J 2003;24:1999–2005.
Fábián E, Varga A. Effect of simvastatin therapy on endothelial function of hypercholesteremic patients with syndrome X. Orv Hetil 2002;143:2067–2071.
Fábián E, Varga A, Picano E, Vajo Z, Rónaszéki A, Csanády M. Effect of simvastatin on endothelial function in cardiac syndrome X patients. Am J Cardiol 2004;94:652–655.
Arroyo-Espliguero R, Kaski J. Microvascular dysfunction in cardiac syndrome X: the role of inflammation. Can Med Assoc J 2006;174:1833.
Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methy-lglutaryl coenzyme A reductase in cardiac syndrome X. Circulation 2004;109:53–58.
Maseri A. National Heart, Lung and Blood Institute, American College of Cardiology Foundation. Women’s Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2–4, 2002: perspective: new frontiers in detection of ischemic heart disease in women. Circulation 2004;109:e62–e63.
Rosano GM, Peters NS, Lefroy D, Lindsay DC, Sarrel PM, Collins P, et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996;28:1500–1505.
Assali AR, Jabara Z, Shafer Z, Solodky A, Herz I, Sclarovsky E, et al. Insulin resistance is increased by transdermal estrogen therapy in postmenopausal women with cardiac syndrome X. Cardiology 2001;95:31–34.
Yeşildağ O, Yazici M, Yilmaz O, Uçar R, Sağkan O. The effect of aminophylline infusion on the exercise capacity in patients with syndrome X. Acta Cardiol 1999;54:335–337.
Elliott PM, Krzyzowska-Dickinson K, Calvino R, Hann C, Kaski JC. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart 1997;77:523–526.
Deng HQ. Pathogenesis and treatment of cardiac syndrome X. South China J Cardiovasc Dis (Chin) 2008;14:390–391.
Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart 2007;93:159–166.
Sgueglia GA, Sestito A. Spinal cord stimulation: a new form of pain modulatory treatment in cardiac syndrome X. Am J Med 2007;120:e17.
Sgueglia GA, Sestito A, Spinelli A, Cioni B, Infusino F, Papacci F, et al. Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation. Heart 2007;93:591–597.
Sestito A, Lanza GA, Le Pera D, De Armas L, Sgueglia GA, Infusino F, et al. Spinal cord stimulation normalizes abnormal cortical pain processing in patients with cardiac syndrome X. Pain 2008;139:82–89.
Spinelli A, Lanza GA, Calcagni ML, Sestito A, Sgueglia GA, Monaco AD, et al. Effect of spinal cord stimulation on cardiac adrenergic nerve function in patients with cardiac syndrome X. J Nucl Cardiol 2008;15:804–810.
Kisely S, Campbell LA, Skerritt P. Psychological interventions for symptomatic management of non-specific chest pain with normal coronary anatomy. Cochrane Database Syst Rev 2005; (1):CD004101.
Tyni-Lenne R, Stryjan S, Eriksson B, Berglund M, Sylven C. Beneficial therapeutic effects of physical training and relaxation therapy in women with coronary syndrome X. Physiother Res Int 2002;7:35–43.
Kronhaus KD, Lawson WE. Enhanced external counterpulsation is an effective treatment for syndrome X. Int J Cardiol 2009;135:256–257.
Zhang MZ, Li XM. Syndrome differentiation and treatment of traditional Chinese medicine on microvascular angina. J Pract Med (Chin) 2001;17:177.
Xu LJ, Wang WY. Effects of quickening the blood and transforming stasis method on blood endothelin-1 level and endothelium-dependent vasodilatated function in patients with syndrom X. Chin Tradit Patent Med (Chin) 2002;24:519–521.
Lin N. Treatment of 11 cases with syndrome X by the method of invigorating qi and warming yangqi. J Pract Tradit Chin Intern Med (Chin) 2007;21 (7):68–69.
Zhang XY. Clinical experience of treatment for 48 patients with cardiac syndrome X by soothing liver and regulating qi. J Emerg Tradit Chin Med (Chin) 2008;17:1608–1609.
Wu HL, Hu LN. Therapeutic observation on the method of regulating the spleen to protect the heart in treating myocardial microvascular lesion. Henan Tradit Chin Med (Chin) 2009;29 (1):45–46.
Mao JY, Zhang ZP, Wang HH, Wang Q, Wang HL, Zhang Y, et al. Clinical analysis of 12 patients with cardiac syndrome X. J Emerg Tradit Chin Med (Chin) 2005;14:368–369.
Mao JY, Wang HH, Ge YB, Wang Q, Zhang QM, Chang YP, et al. Analysis on the characteristics of Chinese medicine syndrome in 51 patients with cardiac syndrome X. J Tradit Chin Med (Chin) 2007;48:1111–1112.
Mao JY, Ge YB, Wang HH, Wang Q, Zhang Y, Yu DL, et al. Summary of 32 patients with cardiac syndrome X treated by TCM therapy of regulating qi relieving chest stuffiness and promoting blood circulation. Chin J Integr Med (Chin) 2007;13:17–21.
Wang XL, Mao JY, Wang HH, Yu KL, Wang Q, Zhang Y, et al. Clinical study on qi-regulating, chest-relaxing and blood-activating therapy for cardiac syndrome X. Shanghai J Tradit Chin Med (Chin) 2009;43:33–35.
Zhu XH, Jia YP. Clinical observation of decoction for removing blood stasis in the treatment of 30 cases of X-syndrome. J Henan Coll Tradit Chin Med (Chin) 2003;18 (2):59.
Zhang XH, Song QF. Taohong Siwu Decoction for the treatment of 20 patients with syndrome X. J Emerg Tradit Chin Med (Chin) 2002;11:137.
Zhao XD. Treatment of 38 patients with cardiac syndrome X by classic formulae. Henan Tradit Chin Med (Chin) 2003;23:10.
Liu H, Hu YC. The effect of Tongxinluo on the vascular endothelial function in patients with syndrome X. J Diffcult Complic Cases (Chin) 2003;4:218.
Bi XP, Cai XJ, Wei F. Clinical effect observation of Tongxinluo Capsule in treating patients with cardiac syndrome X. Hebei Med J (Chin) 2005;27:587.
Feng ZB, Li CM, Cheng RN, Yuan B. The clinical study of cardiac syndrome x treated with Tongxinluo Capsule. J Bethune Milit Med Coll (Chin) 2005;3:25–26.
Li SY, Tang Q. Clinical effect observation of Tongxinluo Capsule combined with Western medicine treatment in 36 cases with cardiac syndrome X. Yunnan J Tradit Chin Med Mater Med (Chin) 2009;30 (11):15–16.
Wang LW, Wang XB, Hu YS, Gao CR. Research on Xuefu Zhuyu Capsules for the treatment of cardiac syndrome X. Beijing J Tradit Chin Med (Chin) 2003;22 (3):65.
Li B, Mao L, Chen RY. Efficacy of Heart-protecting Musk Pill on patients with cardiac syndrome X. Chin J Integr Med Cardio-/Cereb Dis (Chin) 2009;7 (1):88–89.
Niu TF, Li J, Qi HX, Geng Q, Sun XH. Xinxuean Granular infusion for the treatment of 30 cases with cardiac syndrome X. Chin J Integr Med Cardio-/Cereb Dis (Chin) 2008;6:1025–1026.
Li JJ, Wang Y, Nie SP, Li Q, Li YS, Huang Y, et al. Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X. Int J Cardiol (Chin) 2007;122:82–84.
Zhang YL, Liu BX. The clinical study on 40 patients with CSX by the integrative treatment of Western and traditional Chinese medicine. Jiangsu J Tradit Chin Med (Chin) 2010;42 (8):31–32.
Ji YM, Ren BJ. The clinical study on the efficacy of Shuxuetong Injection for CSX. Chin J Integr Med Cardio-/Cereb Dis (Chin) 2009;7:1147–1148.
Wu LH, Sun JL, Wang CY. The clinical study on Shuxuetong Injection for CSX. Chin J Integr Med Cardio-/Cerebr Dis (Chin) 2010;8:652–653.
Larsen W, Mandleco B. Chest pain with angiographic clear coronary arteries: A provider’s approach to cardiac syndrome X. J Am Acad Nurse Pract 2009;21:371–376.
Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National. Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:2993–2999.
Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653–658.
Wu, YL. The related research and treatment of collaterals disease and vascular disease. J Tradit Chin Med (Chin) 2006;47:163–165.
0
Views
737
Downloads
1
CSCD
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
- Tel：010-62886827, 62877592 Fax：010-62874291
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
